• Difloxacin HCl: Quinolone Antimicrobial Antibiotic in Advanc

  2026-06-13

  Difloxacin HCl stands out as a dual-action quinolone antimicrobial antibiotic, enabling both high-precision microbial susceptibility assays and breakthrough multidrug resistance research. Its robust solubility and validated workflow integration make it indispensable for labs focused on bacterial DNA replication inhibition and oncology translational models.

• SPP1 Drives ESCC Progression via M2 Macrophage Infiltration

  2026-06-12

  The reference study identifies SPP1 as a critical mediator of tumour-associated macrophage (TAM) infiltration and M2 polarisation in oesophageal squamous cell carcinoma (ESCC), acting through CD44/PI3K/AKT signaling. This mechanistic insight highlights SPP1’s potential as a therapeutic target and underscores the central role of PI3K/AKT pathway modulation in the ESCC tumour microenvironment.

• 3X (DYKDDDDK) Peptide: Precision Tools for Viral Mechanisms

  2026-06-12

  Explore how the 3X (DYKDDDDK) Peptide empowers virology and translational research, with a mechanistic focus on viral-host protein interactions exemplified by ANKLE2 in Zika virus replication. This article integrates structural insight, experimental best practices, and strategic guidance for advancing recombinant workflows, highlighting APExBIO's leadership in epitope tag innovation.

• Applied Workflows with EZ Cap Cy5 Firefly Luciferase mRNA

  2026-06-11

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) uniquely empowers dual-mode quantification of mRNA delivery and translation, streamlining both workflow optimization and mechanistic troubleshooting. Its Cy5 fluorescence and bioluminescence readouts enable real-time monitoring and rigorous translation efficiency assays, setting a new standard for advanced transfection and imaging protocols.

• Technical Protocols for Calpain Inhibitor I, ALLN (A2602)

  2026-06-11

  Calpain Inhibitor I, ALLN is a potent tool for precise inhibition of calpain and cathepsin proteases in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. This reagent is best used in mechanistic studies where protease activity control is critical, but should not be employed for diagnostic or clinical workflows. Its insolubility in water and sensitivity to storage conditions require careful handling to ensure experimental consistency.

• Shufeng Xingbi Therapy Modulates Th1/Th2 Balance and Microbi

  2026-06-10

  The referenced study investigates how Shufeng Xingbi Therapy (SFXBT) corrects immune imbalance and alters intestinal flora in a rat model of allergic rhinitis (AR). The findings demonstrate significant reduction in AR symptoms, immune modulation, and beneficial shifts in gut microbiota, providing mechanistic insights into traditional Chinese medicine approaches for immune-mediated disorders.

• iRhom2 Modulates Olfactory Receptor Adaptation via ADAM17 Pa

  2026-06-10

  Azzopardi et al. reveal that iRhom2, previously understudied in the nervous system, is uniquely expressed in olfactory sensory neurons (OSNs) and regulates odorant receptor repertoire and adaptation via ADAM17-mediated pathways. This work uncovers a feedback loop linking odor exposure, iRhom2 expression, and transcriptional plasticity, providing new insights for sensory GPCR signaling research.

• Transmission Dynamics of Carbapenemase Genes in CREC in Chin

  2026-06-09

  This study provides a comprehensive analysis of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) across eight teaching hospitals in Guangdong, China, during the COVID-19 pandemic. The findings highlight the predominance of blaNDM-1 genes on plasmids, frequent multidrug resistance, and efficient horizontal gene transfer—offering critical insights for antimicrobial resistance surveillance and experimental modeling.

• Cinoxacin In Vitro: Antibacterial Spectrum and Resistance Pr

  2026-06-09

  This study systematically characterized cinoxacin’s in vitro efficacy against 419 clinical isolates of gram-negative aerobic bacteria, with a focus on urinary pathogens. Key findings include robust activity against Escherichia coli and related species, well-defined MIC ranges, and rapid selection of resistance under serial drug pressure, offering critical insights for urinary tract infection and antibiotic resistance research.

• Cefotaxime: A Third-Generation Cephalosporin for AMR Researc

  2026-06-08

  Cefotaxime, a third-generation cephalosporin antibiotic, is widely used in antimicrobial resistance research for its robust activity against Gram-positive and Gram-negative bacteria. Its resistance to beta-lactamase enzymes and established use in bacterial infection models make it a preferred laboratory standard for benchmarking antibiotic efficacy.

• CF10 and EdU Synergy Drives Telomere Attrition in CRC Cells

  2026-06-08

  The reference study uncovers that the fluoropyrimidine polymer CF10 synergizes with 5-ethynyl-2′-deoxyuridine (EdU) to induce telomere attrition and mitotic catastrophe in colorectal cancer cells, surpassing the efficacy of standard 5-fluorouracil. This mechanistically distinct approach reveals new avenues for telomerase-targeted cancer therapies and highlights the importance of combination strategies for potent genomic destabilization.

• Transmission of Carbapenemase Genes in CREC Across Guangdong

  2026-06-07

  This study provides a detailed molecular characterization of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China. The findings reveal high prevalence, efficient plasmid-mediated transfer of key resistance genes, and distinct epidemiological patterns, offering critical insights for antimicrobial resistance research and infection control strategies.

• Cefodizime: Applied Protocols with a Third-Generation Cephal

  2026-06-06

  Cefodizime’s unique stability against β-lactamases and immunomodulatory effects make it a standout third-generation cephalosporin antibiotic for infectious disease modeling and resistance research. This article translates bench protocols, advanced applications, and critical troubleshooting strategies for maximizing reproducibility and insight with Cefodizime in microbiology laboratories.

• Haloprogin: Broad-Spectrum Topical Antifungal Mechanisms and

  2026-06-05

  The 1970 study by Harrison et al. systematically established Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) as a potent topical antifungal agent with a unique spectrum of activity against dermatophytes, yeasts, and select Gram-positive bacteria. These findings laid the groundwork for reproducible in vitro and in vivo models in dermatophytosis and Candida infection research.

• Sodium Dicloxacillin Monohydrate: Optimizing MSSA Research W

  2026-06-05

  Sodium dicloxacillin monohydrate empowers high-fidelity Gram-positive infection models with tunable experimental dosing and robust, selective detection. This guide details protocol enhancements, troubleshooting, and spectrophotometric innovations that elevate reproducibility in MSSA inhibition studies.

15063 records 1/1005 page Next 12345 下5页 Last page